GlassScriptPhysician profile
Estela Torres
NPI 1487614434
$546.48
in general payments reported to CMS, 2019-2025
14 companies · $60.94 in 2025
The $60.94 reported for 2025 was less than what a typical Women'S Health (Clinical Nurse Specialist) provider received nationally (typical 2025 total: $153).
See the full distribution for Women's Health (Clinical Nurse Specialist)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $83.26 · 2022: $264 · 2023: $105 · 2024: $33.82 · 2025: $60.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $199.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $135.86 | 2021-2025 | Gardasil 9, Vaxneuvance, Gardasil |
| Ironshore Pharmaceuticals INC. | $90.77 | 2022-2023 | Jornay Pm |
| Corium, LLC | $72.05 | 2021-2022 | |
| Sanofi Pasteur INC. | $49.40 | 2023 | |
| Cumberland Pharmaceuticals, INC. | $45.49 | 2022 | |
| Evofem Biosciences, INC. | $23.50 | 2021 | |
| Mayne Pharma Commercial LLC | $20.62 | 2022 | |
| Sumitomo Pharma America, INC. | $17.78 | 2023 | Myfembree |
| Organon LLC | $16.67 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.74 | 2025 | |
| Sage Therapeutics, LLC | $15.57 | 2025 | Zurzuvae |
| Glaxosmithkline, LLC. | $15.16 | 2021 | |
| Lupin INC. | $14.02 | 2021 | |
| Collegium Pharmaceutical, INC. | $13.85 | 2025 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Estela Torres listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.